GlassScriptPhysician profile
Sarah P Adams
NPI 1104888593
$1,357.91
in general payments reported to CMS, 2019-2025
21 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $140 · 2021: $224 · 2022: $245 · 2023: $166 · 2024: $145 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $202.37 | 2019-2023 | Adzenys Xr-Odt |
| Supernus Pharmaceuticals, INC. | $198.25 | 2023-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $181.99 | 2019-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $107.70 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $85.65 | 2020-2023 | Bexsero |
| Pfizer INC. | $82.54 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.29 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $71.22 | 2019-2022 | |
| Corium, LLC | $59.22 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $55.03 | 2021-2025 | |
| Adlon Therapeutics L.P. | $46.24 | 2019-2020 | |
| Aytu Biopharma, INC. | $36.46 | 2020-2021 | |
| Csl Behring | $28.12 | 2025 | Hizentra |
| Azurity Pharmaceuticals, INC. | $21.03 | 2025 | Alvesco |
| Verrica Pharmaceuticals INC. | $19.78 | 2024 | Ycanth |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $17.59 | 2020 | |
| Amneal Pharmaceuticals LLC | $16.54 | 2023 | Lyvispah |
| Kaleo, INC. | $15.15 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.94 | 2024 | Flumist Quadrivalent |
| Teva Pharmaceuticals USA, INC. | $13.43 | 2021 | |
| Boston Scientific Corporation | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.